Cargando…

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer

BACKGROUND: The primary goal of this study was to determine overall survival (OS) in patients who underwent local treatment (metastasectomy or stereotactic body radiotherapy [SBRT]) or systemic therapy (chemotherapy or targeted therapy) for oligometastatic esophagogastric cancer. The secondary goal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kroese, Tiuri E., Buijs, George S., Burger, Matthijs D. L., Ruurda, Jelle P., Mook, Stella, Brosens, Lodewijk A. A., van Rossum, Peter S. N., van Hillegersberg, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Thoracic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246791/ https://www.ncbi.nlm.nih.gov/pubmed/35381938 http://dx.doi.org/10.1245/s10434-022-11541-0

Ejemplares similares

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
por: Kroese, Tiuri E., et al.
Publicado: (2022)

ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Long-term survival after sequential local treatments for oligometastatic esophageal squamous cell carcinoma: A case report
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
por: Visser, E., et al.
Publicado: (2016)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Optimal timing for lung metastasectomy in patients with colorectal cancer
por: Ichinose, Junji, et al.
Publicado: (2022)

Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung
por: Gusho, Charles A, et al.
Publicado: (2021)

Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma
por: Frederiks, Charlotte N., et al.
Publicado: (2023)

Prognostic gene expression profiling in esophageal cancer: a systematic review
por: Visser, Els, et al.
Publicado: (2016)

Metastasectomy of oligometastatic urothelial cancer: a single-center experience
por: Muilwijk, Tim, et al.
Publicado: (2020)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy
por: Stork, Theresa, et al.
Publicado: (2022)

Metastasectomy for colorectal pulmonary metastases: a survey among members of the European Society of Thoracic Surgeons
por: van Dorp, Martijn, et al.
Publicado: (2023)

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer
por: Borggreve, Alicia S., et al.
Publicado: (2019)

Impact of Age on the Treatment and Survival in Esophagogastric Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2023)

A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study
por: Brenkman, Hylke J. F., et al.
Publicado: (2017)

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
por: Ahmed, Kamran A., et al.
Publicado: (2013)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era
por: Kanzaki, Ryu, et al.
Publicado: (2020)

Key points in pulmonary metastasectomy from colorectal carcinoma: European Society of Thoracic Surgeons survey analysis
por: Cardillo, Giuseppe, et al.
Publicado: (2023)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Surgical management of a perforated ‘black oesophagus’
por: Kuiper, Gino M., et al.
Publicado: (2021)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
por: Kalman, Noah S., et al.
Publicado: (2018)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
por: Ashrafi, Akbar N., et al.
Publicado: (2020)

Distal Versus Total D2-Gastrectomy for Gastric Cancer: a Secondary Analysis of Surgical and Oncological Outcomes Including Quality of Life in the Multicenter Randomized LOGICA-Trial
por: de Jongh, Cas, et al.
Publicado: (2023)

Intravascular Placement of Metallic Coils as Lung Tumor Markers for CyberKnife Stereotactic Radiation Therapy
por: Karaman, Kutlay, et al.
Publicado: (2015)

Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)

Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
por: Hou, Xiaorong, et al.
Publicado: (2019)

Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study
por: Defize, Ingmar L., et al.
Publicado: (2023)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer
por: van der Sluis, P. C., et al.
Publicado: (2015)

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series
por: Palmer, John P., et al.
Publicado: (2023)

The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy—rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial
por: Begum, Housne, et al.
Publicado: (2022)

Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial
por: de Jongh, Cas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jc9hpsc5u1fnbs7np0bbrsn7fu